Oral anticoagulants and risk of dementia: A systematic review and meta-analysis of observational studies and randomized controlled trials

[1]  Rahul Wadke,et al.  Atrial fibrillation. , 2022, Disease-a-month : DM.

[2]  Dongfang Li,et al.  Relationship of Anticoagulant Therapy With Cognitive Impairment Among Patients With Atrial Fibrillation: A Meta‐Analysis and Systematic Review , 2018, Journal of cardiovascular pharmacology.

[3]  C. Askew,et al.  The Effect of Non-Stroke Cardiovascular Disease States on Risk for Cognitive Decline and Dementia: A Systematic and Meta-Analytic Review , 2018, Neuropsychology Review.

[4]  M. Rosenqvist,et al.  Less dementia with oral anticoagulation in atrial fibrillation , 2018, European heart journal.

[5]  B. Gersh,et al.  Efficacy of Warfarin Anticoagulation and Incident Dementia in a Community‐Based Cohort of Atrial Fibrillation , 2018, Mayo Clinic proceedings.

[6]  D. McManus,et al.  Atrial fibrillation, cognition and dementia: A review , 2017, Journal of cardiovascular electrophysiology.

[7]  H. May,et al.  Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long‐term warfarin , 2017, American heart journal.

[8]  R. Payne,et al.  Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study , 2017, BMJ Open.

[9]  D. Lane,et al.  Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review. , 2016, Age and ageing.

[10]  H. May,et al.  Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation. , 2016, The American journal of cardiology.

[11]  H. May,et al.  Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications , 2016, Journal of the American Heart Association.

[12]  C. Jack,et al.  Atrial fibrillation, cognitive impairment, and neuroimaging , 2016, Alzheimer's & Dementia.

[13]  G. Lip,et al.  Risk and prediction of dementia in patients with atrial fibrillation--a nationwide population-based cohort study. , 2015, International journal of cardiology.

[14]  Nancy D Berkman,et al.  Grading the strength of a body of evidence when assessing health care interventions: an EPC update. , 2015, Journal of clinical epidemiology.

[15]  T. Chao,et al.  Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study. , 2015, International journal of cardiology.

[16]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[17]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[18]  S. Kalantarian,et al.  Association Between Atrial Fibrillation and Silent Cerebral Infarctions , 2014, Annals of Internal Medicine.

[19]  Mary Ganguli,et al.  Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. , 2014, Clinics in geriatric medicine.

[20]  G. Lip,et al.  Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study) , 2014, Stroke.

[21]  Alexander Parkhomenko,et al.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.

[22]  F. Gaita,et al.  Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function. , 2013, Journal of the American College of Cardiology.

[23]  M. Blaha,et al.  Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects. , 2013, Mayo Clinic proceedings.

[24]  C. McKevitt,et al.  Long-Term Effects of Secondary Prevention on Cognitive Function in Stroke Patients , 2013, Circulation.

[25]  W. Kukull,et al.  Antithrombotic medication use and dementia incidence among people with mild cognitive impairment and atrial fibrillation , 2013, Alzheimer's & Dementia.

[26]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[27]  A. Maggioni,et al.  Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study. , 2013, European journal of internal medicine.

[28]  S. Kalantarian,et al.  Cognitive Impairment Associated With Atrial Fibrillation , 2013, Annals of Internal Medicine.

[29]  A. Wimo,et al.  The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.

[30]  Dhanunjaya R. Lakkireddy,et al.  Atrial fibrillation and the risk of incident dementia: a meta-analysis. , 2012, Heart rhythm.

[31]  G. Lip,et al.  Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report , 2012, Chest.

[32]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[33]  J. Potter,et al.  Atrial fibrillation and incidence of dementia , 2011, Neurology.

[34]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[35]  B. Horne,et al.  Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. , 2010, Heart rhythm.

[36]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[37]  O. Hanon,et al.  Vascular risk factors, cognitve decline, and dementia , 2008, Vascular health and risk management.

[38]  A. D. de Craen,et al.  Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia. , 2005, American journal of epidemiology.

[39]  D. Stott,et al.  Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation , 2004, Journal of thrombosis and haemostasis : JTH.

[40]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[41]  G. Mead,et al.  Association between cognitive impairment and atrial fibrillation: a systematic review. , 2001, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[42]  B. Stricker,et al.  Confounding by indication: an example of variation in the use of epidemiologic terminology. , 1999, American journal of epidemiology.

[43]  J. Zhang,et al.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. , 1998, JAMA.

[44]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[45]  D. Maucort-Boulch.  Odds Ratio , Hazard Ratio and Relative Risk Janez Stare , 2016 .

[46]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[47]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.